BioSig Technologies, Inc. announces an underwritten public offering of shares of common stock to purchase gold bullion and support its investment policy.
Clear Street and Needham & Company are the joint book-running managers of the offering.
The offering is being made pursuant to a shelf registration statement on Form S-3 declared effective by the SEC on December 17, 2024.
Proposed Public Offering
BioSig Technologies, Inc. plans to offer shares of common stock to purchase gold bullion and support working capital needs.
Underwritten Offering
Clear Street and Needham & Company are acting as the joint book-running managers for the offering.
Registration Statement
The offering is based on a shelf registration statement on Form S-3 declared effective by the SEC on December 17, 2024.
- BioSig intends to use the net proceeds to acquire gold bullion as per its investment policy, enhance working capital, and fulfill general corporate necessities.
- The joint book-running managers, Clear Street and Needham & Company, will oversee the offering process to ensure its successful completion.
The proposed public offering by BioSig Technologies Inc. reflects the company's strategic focus on acquiring gold bullion and strengthening its financial position. The collaboration with Clear Street and Needham & Company demonstrates a commitment to a successful offering process.